Ryan Larson

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Ryan Larson and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Ryan

Ryan Larson

VP, Head of Translational Sciences

Umoja Biopharma

Ryan is the VP, Head of Immunology at Umoja Biopharma where he is responsible for advancing off-the-shelf in vivo lentiviral vector and ex vivo cell-based CAR T cell therapies to the clinic.

Talks About
#cellculture #immunology #translationalsciences

Preferred Locations
#NorthAmerica

Speaking Engagements

In Vivo Engineering Of Therapeutic Cells Summit

Paid

In vivo gene engineering is fast becoming known as the future of cell and gene therapy with incredible amounts of investment seen in 2021, including the recent Moderna and Metagenomi collaboration alongside the partnership between Abintus Bio and MSKCC, and Tidal acquisition by Sanofi.

12-14 July 2022

Healthcare

Next Generation CAR & T Cell Therapies 2023

Paid

The exploration of novel cell lines to be used in CAR-based therapies has opened many possibilities for future ‘CGT 2.0’ treatments, both allogeneic and autologous. Join us at our new CAR & T Cell Therapies track within BPI West to learn more about these emerging CGT 2.0 cell lines, and the opportunities they hold.

27 February-02 March 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Ryan Larson

VP, Head of Translational Sciences

Speaking Engagements

In Vivo Engineering Of Therapeutic Cells Summit

Next Generation CAR & T Cell Therapies 2023